Create a narrative

Vanda Pharmaceuticals Community

NasdaqGM:VNDA Community

1 Narratives written by author
0 Comments on narratives written by author
24 Fair Values set on narratives written by author

Create a narrative

Vanda Pharmaceuticals

AN

AnalystConsensusTarget

Consensus Narrative from 3 Analysts

New Indications And Pipeline Advances Will Strengthen Position

Key Takeaways Expansion of Fanapt's sales and marketing efforts is expected to drive significant revenue growth through increased brand awareness and prescriber engagement. New drug applications and developments in inflammation treatments offer potential diversification and new revenue streams for Vanda Pharmaceuticals.

US$12.67

FV

63.9% undervalued

24.01%

Revenue growth p.a.

0

0

13

4 days ago